Guardian Pharmacy Services Share Price (NYSE: GRDN)

$26.3

▲

0.15

(0.57%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Guardian Pharmacy Services Stock chart to analyse performance

Guardian Pharmacy Services stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$26.08
Today's High:$26.65
$26.30
0.84%
Downside
Day's Volatility :2.14%
Upside
1.31%
52 Weeks Low:$14.16
52 Weeks High:$26.91
$26.30
46.16%
Downside
52 Weeks Volatility :47.38%
Upside
2.27%

Guardian Pharmacy Services Stock Returns

Period	Guardian Pharmacy Services Inc.	Index (Russel 2000)
3 Months	23.44%	0.0%
6 Months	38.97%	0.0%
1 Year	64.25%	0.0%
3 Years	64.25%	-4.7%

Guardian Pharmacy Services Inc. Key Stats

Check Guardian Pharmacy Services key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$26.15
Open	$26.35
Today's High	$26.65
Today's Low	$26.08
Market Capitalization	$1.7B
Today's Volume	$373.8K
52 Week High	$26.91
52 Week Low	$14.16
Revenue TTM	$1.3B
EBITDA	$-36.9M
Earnings Per Share (EPS)	$-1.48
Profit Margin	-5.19%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-52.74%

Stock Returns calculator for Guardian Pharmacy Services Stock including INR - Dollar returns

The Guardian Pharmacy Services stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Guardian Pharmacy Services investment value today

Current value as on today

₹1,69,659

Returns

₹69,659

(+69.66%)

Returns from Guardian Pharmacy Services Stock

₹64,375 (+64.38%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Guardian Pharmacy Services Stock

14%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Guardian Pharmacy Services Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Guardian Pharmacy Services Stock

Rating

Trend

Guardian Pharmacy Services Share Price Target

What analysts predicted

Upside of 3.93%

Target:

$27.33

Current:

$26.30

Guardian Pharmacy Services share price target is $27.33, a slight Upside of 3.93% compared to current price of $26.30 as per analysts' prediction.

Guardian Pharmacy Services Stock Insights

Price Movement
In the last 1 month, GRDN stock has moved up by 28.3%

Guardian Pharmacy Services Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$698.3M	↑ 16.31%
Net Income	$21.7M	↑ 48.15%
Net Profit Margin	3.11%	↑ 0.67%

	FY20	Y/Y Change
Revenue	$736.0M	↑ 5.39%
Net Income	$19.9M	↓ 8.29%
Net Profit Margin	2.71%	↓ 0.4%

	FY21	Y/Y Change
Revenue	$792.1M	↑ 7.62%
Net Income	$16.3M	↓ 18.2%
Net Profit Margin	2.06%	↓ 0.65%

	FY22	Y/Y Change
Revenue	$908.9M	↑ 14.75%
Net Income	$35.4M	↑ 117.12%
Net Profit Margin	3.9%	↑ 1.84%

	FY23	Y/Y Change
Revenue	$1.0B	↑ 15.1%
Net Income	$23.9M	↓ 32.52%
Net Profit Margin	2.28%	↓ 1.62%

	FY24	Y/Y Change
Revenue	$1.2B	↑ 17.42%
Net Income	$-87.3M	↓ 465.19%
Net Profit Margin	-7.11%	↓ 9.39%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$275.4M	↓ 2.01%
Net Income	$2.8M	↓ 76.82%
Net Profit Margin	1.01%	↓ 3.27%

	Q2 FY24	Q/Q Change
Revenue	$300.0M	↑ 8.94%
Net Income	$10.6M	↑ 281.34%
Net Profit Margin	3.54%	↑ 2.53%

	Q3 FY24	Q/Q Change
Revenue	$314.4M	↑ 4.78%
Net Income	$-112.6M	↓ 1160.24%
Net Profit Margin	-35.83%	↓ 39.37%

	Q4 FY24	Q/Q Change
Revenue	$338.6M	↑ 7.69%
Net Income	$11.9M	↓ 110.6%
Net Profit Margin	3.53%	↑ 39.36%

	Q1 FY25	Q/Q Change
Revenue	$329.3M	↓ 2.74%
Net Income	$9.4M	↓ 20.89%
Net Profit Margin	2.87%	↓ 0.66%

	Q2 FY25	Q/Q Change
Revenue	$344.3M	↑ 4.56%
Net Income	$9.0M	↓ 4.42%
Net Profit Margin	2.62%	↓ 0.25%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$143.5M	↑ 16.6%

	FY20	Y/Y Change
Profit	$147.0M	↑ 2.47%

	FY21	Y/Y Change
Profit	$161.3M	↑ 9.7%

	FY22	Y/Y Change
Profit	$185.9M	↑ 15.26%

	FY23	Y/Y Change
Profit	$208.3M	↑ 12.08%

	FY24	Y/Y Change
Profit	$244.4M	↑ 17.31%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$55.1M	↑ 0.96%

	Q2 FY24	Q/Q Change
Profit	$61.3M	↑ 11.23%

	Q3 FY24	Q/Q Change
Profit	$60.9M	↓ 0.67%

	Q4 FY24	Q/Q Change
Profit	$67.1M	↑ 10.23%

	Q1 FY25	Q/Q Change
Profit	$64.3M	↓ 4.11%

	Q2 FY25	Q/Q Change
Profit	$68.1M	↑ 5.9%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$56.2M	↑ 28.59%
Investing Cash Flow	$-16.6M	↓ 20.04%
Financing Cash Flow	$-41.5M	↑ 97.13%

	FY20	Y/Y Change
Operating Cash Flow	$52.6M	↓ 6.32%
Investing Cash Flow	$-12.2M	↓ 26.61%
Financing Cash Flow	$-34.3M	↓ 17.53%

	FY21	Y/Y Change
Operating Cash Flow	$58.5M	↑ 11.19%
Investing Cash Flow	$-13.1M	↑ 7.98%
Financing Cash Flow	$-36.8M	↑ 7.37%

	FY22	Y/Y Change
Operating Cash Flow	$48.5M	↓ 17.05%
Investing Cash Flow	$-17.9M	↑ 36.13%
Financing Cash Flow	$-45.0M	↑ 22.4%

	FY23	Y/Y Change
Operating Cash Flow	$70.8M	↑ 45.95%
Investing Cash Flow	$-13.4M	↓ 24.91%
Financing Cash Flow	$-57.2M	↑ 27.11%

	FY24	Y/Y Change
Operating Cash Flow	$58.0M	↓ 18.16%
Investing Cash Flow	$-30.4M	↑ 126.23%
Financing Cash Flow	$-23.6M	↓ 58.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$8.7M	↓ 40.54%
Investing Cash Flow	$-3.6M	↑ 213.69%
Financing Cash Flow	$-5.6M	↓ 57.56%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$29.1M	↑ 236.64%
Investing Cash Flow	$-13.1M	↑ 264.2%
Financing Cash Flow	$-14.7M	↑ 160.29%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.2M	↓ 107.43%
Investing Cash Flow	$-7.1M	↓ 45.96%
Financing Cash Flow	$44.9M	↓ 406.36%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$22.3M	↓ 1132.21%
Investing Cash Flow	$-6.6M	↓ 6.45%
Financing Cash Flow	$-48.3M	↓ 207.45%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$17.6M	↓ 21.43%
Investing Cash Flow	$-5.5M	↓ 16.29%
Financing Cash Flow	$-2.7M	↓ 94.48%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$19.9M	↑ 13.6%
Investing Cash Flow	$-13.0M	↑ 134.52%
Financing Cash Flow	$-2.1M	↓ 20.71%

Guardian Pharmacy Services Technicals Summary

Sell

Neutral

Buy

Guardian Pharmacy Services is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Guardian Pharmacy Services Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Guardian Pharmacy Services Inc.	25.74%	38.97%	64.25%	64.25%	64.25%
Fresenius Medical Care Ag	2.27%	9.13%	33.85%	52.16%	-38.9%
Hca Holdings, Inc.	13.07%	29.66%	1.97%	102.37%	200.76%
Encompass Health Corporation	12.13%	21.96%	30.5%	149.95%	85.63%
Universal Health Services Inc.	11.44%	3.32%	-23.19%	86.77%	64.27%
Tenet Healthcare Corp.	16.59%	47.97%	14.02%	226.96%	548.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Guardian Pharmacy Services Inc.	NA	NA	NA	0.97	-0.53	-0.11	NA	2.68
Fresenius Medical Care Ag	19.34	19.34	0.42	1.96	0.06	0.03	0.03	45.23
Hca Holdings, Inc.	16.98	16.98	1.32	26.34	1.36	0.12	0.01	-18.61
Encompass Health Corporation	23.73	23.73	NA	5.28	0.25	0.09	0.01	22.6
Universal Health Services Inc.	9.57	9.57	1.87	20.44	0.19	0.08	0.0	110.47
Tenet Healthcare Corp.	11.59	11.59	0.85	15.81	0.3	0.08	NA	42.44

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Guardian Pharmacy Services Inc.	NA	$1.7B	64.25%	NA	-5.19%
Fresenius Medical Care Ag	Hold	$14.8B	-38.9%	19.34	3.36%
Hca Holdings, Inc.	Buy	$95.3B	200.76%	16.98	8.21%
Encompass Health Corporation	Buy	$12.4B	85.63%	23.73	9.22%
Universal Health Services Inc.	Hold	$11.6B	64.27%	9.57	7.66%
Tenet Healthcare Corp.	Buy	$16.3B	548.52%	11.59	7.18%

About Guardian Pharmacy Services Inc.

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Organization	Guardian Pharmacy Services
Employees	3400
CEO	Mr. Fred P. Burke
Industry	Miscellaneous

Key Management of Guardian Pharmacy Services Inc.

Name	Title
Mr. Fred P. Burke	CEO, President & Director
Mr. David K. Morris	CFO, Executive VP & Director
Mr. Kendall Forbes R.Ph.	Executive Vice President of Sales & Operations
Mr. David Martin	Vice President of Technology & Senior Security Officer
Ms. Ashley Stockton	Head of Investor Relations & Senior Director
Mr. Douglas Towns	VP & General Counsel
Ms. Vicki Crabtree	Vice President of Human Resources
Mr. Rockford Anderson	President of Right Dose Pharmacy - Iowa
Mr. Brian Rosati	President of Guardian Pharmacy of Daytona
Ms. Robin Smith	President of East Tennessee Pharmacy Services

Important FAQs about investing in GRDN Stock from India :

What is Guardian Pharmacy Services share price today?

Guardian Pharmacy Services share price today is $26.30 as on August 30, 2025 at 1:29 am IST at the close of the market. Guardian Pharmacy Services share today touched a day high of $26.65 and a low of $26.08.

What is the 52 week high and 52 week low for Guardian Pharmacy Services share?

Guardian Pharmacy Services share touched a 52 week high of $26.91 and a 52 week low of $14.16. Guardian Pharmacy Services stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $26.30, lower by 2.27% versus the 52 week high.

How to invest in Guardian Pharmacy Services Stock (GRDN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Guardian Pharmacy Services on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Guardian Pharmacy Services Shares that will get you 0.0570 shares as per Guardian Pharmacy Services share price of $26.30 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Guardian Pharmacy Services Stock (GRDN) from India?

Indian investors can start investing in Guardian Pharmacy Services (GRDN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Guardian Pharmacy Services stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Guardian Pharmacy Services share’s latest price of $26.30 as on August 30, 2025 at 1:29 am IST, you will get 0.3802 shares of Guardian Pharmacy Services. Learn more about fractional shares .

What are the returns that Guardian Pharmacy Services has given to Indian investors in the last 5 years?

Guardian Pharmacy Services stock has given 64.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?